Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CARAMEL: Atorvastatin and Vascular Inflammation in T2DM
NCT05730634Completed
- Sponsor
- University of Amsterdam
- Start
- Jun 2019
- Primary completion
- May 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of atorvastatin in vasculitis, sponsored by University of Amsterdam. Primary endpoint: 68Ga-DOTATATE uptake in coronary arteries at 3 months. Started Jun 2019; status: completed.
02
Drugs
atorvastatin
03
Conditions
vasculitis
Beyond the preview
Go deeper on NCT05730634.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05730634.